Filing Details

Accession Number:
0001178913-14-002866
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-08 15:28:58
Reporting Period:
2014-09-04
Filing Date:
2014-09-08
Accepted Time:
2014-09-08 15:28:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1176309 Oramed Pharmaceuticals Inc. ORMP Pharmaceutical Preparations (2834) 980376008
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1409232 Miriam Kidron 2 Elza Street
Jerusalem L3 93706
Chief Technology Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-09-04 8,301 $9.41 134,513 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.25 to $9.57, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.